The anti-inflammatory effects of macrolides.
作者信息
Wales D, Woodhead M
机构信息
Department of Respiratory Medicine, Manchester Royal Infirmary, UK.
出版信息
Thorax. 1999 Aug;54 Suppl 2(Suppl 2):S58-62. doi: 10.1136/thx.54.2008.s58.
Abstract
摘要
相似文献
1
The anti-inflammatory effects of macrolides.大环内酯类药物的抗炎作用。
Thorax. 1999 Aug;54 Suppl 2(Suppl 2):S58-62. doi: 10.1136/thx.54.2008.s58.
2
Anti-inflammatory properties of macrolides.大环内酯类药物的抗炎特性。
Pediatr Infect Dis J. 2007 Jan;26(1):75-6. doi: 10.1097/01.inf.0000253037.90204.9f.
3
[Clinical applications of macrolides for respiratory diseases in China].[大环内酯类药物在中国呼吸系统疾病中的临床应用]
Zhonghua Jie He He Hu Xi Za Zhi. 2008 Oct;31(10):725-6.
4
"Multi-effect" macrolides.“多效性”大环内酯类药物
Intern Med. 2000 Aug;39(8):599-600. doi: 10.2169/internalmedicine.39.599.
5
N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity.N'-取代-2'-O,3'-N-碳亚氨桥大环内酯类化合物：新型无抗菌活性的抗炎大环内酯类化合物。
J Med Chem. 2012 Jul 12;55(13):6111-23. doi: 10.1021/jm300356u. Epub 2012 Jun 25.
6
[Chronic pharyngitis and macrolides].
Acta Otorrinolaringol Esp. 2002 Jun-Jul;53(6):441-3. doi: 10.1016/s0001-6519(02)78334-9.
7
Anti-inflammatory effects of macrolide antibiotics.大环内酯类抗生素的抗炎作用。
Eur J Pharmacol. 2001 Oct 19;429(1-3):209-29. doi: 10.1016/s0014-2999(01)01321-8.
8
[Usefulness of macrolides as anti-inflammatories in respiratory diseases].
Arch Bronconeumol. 2010 May;46(5):244-54. doi: 10.1016/j.arbres.2009.10.008. Epub 2009 Dec 4.
9
Dexamethasone for bronchiolitis.
N Engl J Med. 2007 Oct 18;357(16):1659; author reply 1660.
10
[Nonantibiotic properties of macrolides and their role in modulation of the inflammatory reaction].
Eksp Klin Farmakol. 2012;75(12):41-5.
引用本文的文献
1
Neutrophil Extracellular Traps: An Emerging Therapeutic Target to Improve Infectious Disease Outcomes.中性粒细胞胞外陷阱：改善传染病结局的新兴治疗靶点。
J Infect Dis. 2024 Aug 16;230(2):514-521. doi: 10.1093/infdis/jiae252.
2
Augmentation of Therapeutic Efficacy of Extraction of Causative Teeth by Irrigation for Odontogenic Maxillary Sinusitis.通过冲洗增强治疗牙源性上颌窦炎的疗效。
In Vivo. 2024 May-Jun;38(3):1236-1242. doi: 10.21873/invivo.13560.
3
Mechanism of action, resistance, synergism, and clinical implications of azithromycin.阿奇霉素的作用机制、耐药性、协同作用及其临床意义。
J Clin Lab Anal. 2022 Jun;36(6):e24427. doi: 10.1002/jcla.24427. Epub 2022 Apr 21.
4
Antibiotic therapy for chronic infection with <I>Burkholderia cepacia</I> complex in people with cystic fibrosis.囊性纤维化患者感染洋葱伯克霍尔德菌复合体的慢性感染的抗生素治疗。
Cochrane Database Syst Rev. 2021 Dec 10;12(12):CD013079. doi: 10.1002/14651858.CD013079.pub3.
5
Intestinal Organoids in Colitis Research: Focusing on Variability and Cryopreservation.结肠炎研究中的肠道类器官：聚焦变异性与冷冻保存
Stem Cells Int. 2021 Sep 17;2021:9041423. doi: 10.1155/2021/9041423. eCollection 2021.
6
Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19.阿奇霉素的免疫调节作用再探：在 COVID-19 中的潜在应用。
Front Immunol. 2021 Feb 12;12:574425. doi: 10.3389/fimmu.2021.574425. eCollection 2021.
7
Erythromycin inhibits neutrophilic inflammation and mucosal disease by upregulating DEL-1.红霉素通过上调 DEL-1 抑制中性粒细胞炎症和黏膜疾病。
JCI Insight. 2020 Aug 6;5(15):136706. doi: 10.1172/jci.insight.136706.
8
Aminoglycosides can be a better choice over macrolides in COVID-19 regimen: Plausible mechanism for repurposing strategy.在新冠病毒治疗方案中，氨基糖苷类药物可能比大环内酯类药物是更好的选择：重新利用策略的合理机制。
Med Hypotheses. 2020 Nov;144:109984. doi: 10.1016/j.mehy.2020.109984. Epub 2020 Jun 10.
9
Antibiotic therapy for chronic infection with Burkholderia cepacia complex in people with cystic fibrosis.囊性纤维化患者中针对洋葱伯克霍尔德菌复合群慢性感染的抗生素治疗。
Cochrane Database Syst Rev. 2019 Jun 13;6(6):CD013079. doi: 10.1002/14651858.CD013079.pub2.
10
Macrolides in critically ill patients with Middle East Respiratory Syndrome.重症中东呼吸综合征患者的大环内酯类药物。
Int J Infect Dis. 2019 Apr;81:184-190. doi: 10.1016/j.ijid.2019.01.041. Epub 2019 Jan 25.
本文引用的文献
1
A pilot study of low-dose erythromycin in bronchiectasis.低剂量红霉素治疗支气管扩张症的一项初步研究。
Eur Respir J. 1999 Feb;13(2):361-4. doi: 10.1183/09031936.99.13236199.
2
Erythromycin and clarithromycin attenuate cytokine-induced endothelin-1 expression in human bronchial epithelial cells.红霉素和克拉霉素可减弱细胞因子诱导的人支气管上皮细胞中内皮素-1的表达。
Eur Respir J. 1998 Jul;12(1):57-63. doi: 10.1183/09031936.98.12010057.
3
Erythromycin inhibits tumor necrosis factor alpha and interleukin 6 production induced by heat-killed Streptococcus pneumoniae in whole blood.红霉素可抑制全血中热灭活肺炎链球菌诱导产生的肿瘤坏死因子α和白细胞介素6。
Antimicrob Agents Chemother. 1998 Jul;42(7):1605-9. doi: 10.1128/AAC.42.7.1605.
4
Roxithromycin inhibits cytokine production by and neutrophil attachment to human bronchial epithelial cells in vitro.罗红霉素在体外可抑制细胞因子的产生以及中性粒细胞与人类支气管上皮细胞的黏附。
Antimicrob Agents Chemother. 1998 Jun;42(6):1499-502. doi: 10.1128/AAC.42.6.1499.
5
Elevated concentrations of defensins in bronchoalveolar lavage fluid in diffuse panbronchiolitis.弥漫性泛细支气管炎患者支气管肺泡灌洗液中防御素浓度升高。
Eur Respir J. 1998 Jan;11(1):104-11. doi: 10.1183/09031936.98.11010104.
6
Long-term azithromycin may improve lung function in children with cystic fibrosis.长期使用阿奇霉素可能改善囊性纤维化患儿的肺功能。
Lancet. 1998 Feb 7;351(9100):420. doi: 10.1016/S0140-6736(05)78360-4.
7
Elevated levels of soluble adhesion molecules in serum of patients with diffuse panbronchiolitis.弥漫性泛细支气管炎患者血清中可溶性黏附分子水平升高。
Chest. 1997 Dec;112(6):1615-21. doi: 10.1378/chest.112.6.1615.
8
Macrolides for the treatment of Pseudomonas aeruginosa infections?大环内酯类药物用于治疗铜绿假单胞菌感染？
J Antimicrob Chemother. 1997 Aug;40(2):153-5. doi: 10.1093/jac/40.2.153.
9
A possible association of Chlamydia pneumoniae infection and acute myocardial infarction in patients younger than 65 years of age.
Chest. 1997 Aug;112(2):309-12. doi: 10.1378/chest.112.2.309.
10
Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group.罗红霉素治疗非Q波冠状动脉综合征的随机试验：ROXIS初步研究。ROXIS研究组
Lancet. 1997 Aug 9;350(9075):404-7. doi: 10.1016/s0140-6736(97)07201-2.
Zotero 插件